Central Illinois Hematology Oncology Conference: Emphasis on Precision-Guided Management

Peoria, IL US
April 6, 2024

The "Central Illinois Hematology Oncology Conference: Emphasis on Precision-Guided Management" is an accredited continuous education to improve the care of cancer patients by educating cancer care providers about precision-guided management in hematology and oncology. Regional and national experts in the field will share comprehensive insights into the actionable molecular variations seen in common cancers. The event's format is tailored to promote active learning, enhance knowledge retention, and encourage practitioners to apply fresh insights into their clinical routines. Through didactics, case-centric discussions, and lively Q&A sessions, attendees can gain clarity, address uncertainties, and interact with the field's pioneers. This conference aims to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in precision-guided management in hematology and oncology.  It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care.

 

Target Audience

  • Hematologists/ Oncologists
  • Oncology Fellows
  • NPs/PAs
  • Pharmacists
  • Nurses
  • Researchers and others

Organizing Committee 

Course Director:

Binay Shah, MD, MHA Binaytara Foundation

Conference Chair

Krishna Rao, MD, PhD - Southern Illinois University School of Medicine

Organizing Committee

Noor Naffakh, PharmD - University of Illinois Chicago

Rakesh Mandal, MD - OSF Healthcare

Venue Information

A limited number of rooms have been booked at Peoria Marriott Pere Marquette at a discounted nightly rate of $139 per room for this conference's attendees and sponsors. Please book your room at the link here  by March 5, 2024 to receive the discounted group rate. 

Learning Objectives

  1. Review common molecular abnormalities in various cancers and the optimal timing to test for these abnormalities.
  2. Interpret the findings from next-generation sequencing and other biomarkers that indicate the likelihood of response to specific therapies while also understanding the inherent challenges.
  3. Apply optimal strategies centered on molecular-targeted treatments in the management of patients with cancer.
  4. Summarize emerging research, the mechanism of action, and the significance of new molecular-targeted treatments in managing cancer patients.

GLOBAL ONCOLOGY PROJECT

Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/

Course summary
Available credit: 
  • 6.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.
Course opens: 
11/06/2023
Course expires: 
06/30/2024
Event starts: 
04/06/2024 - 7:00am PDT
Event ends: 
04/06/2024 - 4:00pm PDT
Cost:
$150.00

April 6, 2024

All times below are listed in Central Standard Time (CST).

07:00 AM – 08:00 AM  Registration, Breakfast, & Exhibits


08:00 AM – 08:05 AM  Welcome 

08:05 AM – 08:25 AM  Binaytara Foundation's Efforts in Improving Cancer Care Disparities 


08:25 AM – 09:10 AM  Session 1 - Precision Oncology - General Concepts

Moderator: Krishna Rao, MD, PhD

08:25 AM – 08:40 AM  Solid Tumor Genomic Testing - Frank Weinberg, MD, PhD

08:40 AM – 08:55 AM  Liquid Biopsy - Pradeep Singh Chauhan, PhD

08:55 AM – 09:10 AM  Q and A


09:10 AM – 10:25 AM  Session 2 - Hematology

Moderator: James L. Wade III, MD, FACP, FASCO

09:10 AM – 09:25 AM  Multiple Myeloma - Matías E. Sánchez, MD

09:25 AM – 09:40 AM  Myeloid Disorders - Noah Birch, MD

09:40 AM – 09:55 AM  CLL - Parameswaran Venugopal, MD

09:55 AM – 10:25 AM  Case-Based Presentation - Karen Sweiss, PharmD and Waqas Azhar, MD


10:25 AM – 10:45 AM  Break & Exhibits


10:45 AM – 11:45 AM  Session 3 - Breast Cancer

Moderator: Melanie Barnard, MD

10:45 AM – 11:00 AM  Genomics in Breast Cancer - Nusayba Bagegni, MD

11:00 AM – 11:45 AM  Case-Based Discussion - Oana Danciu, MD and Rakesh Mandal, MD


11:45 AM – 12:45 PM  Lunch & Exhibits


12:45 PM – 01:45 PM  Session 4 - GU Oncology

Moderator: Deepak Kilari, MD

12:45 PM – 01:00 PM  Keynote Speech: Recent Advances in Molecular Guided Treatment of GU Malignancies - Natalie Reizine, MD

01:00 PM – 01:45 PM  Case-Based Discussion - Karine Tawagi, MD and Kimberly Ku, MD


01:45 PM – 02:45 PM  Session 5 - Lung Cancer

Moderator: Ryan Nguyen, DO

01:45 PM – 02:00 PM  Keynote Speech: Advances in Precision-guided Management of Lung Cancers - Siddhartha Devarakonda, MD

02:00 PM – 02:45 PM  Case-Based Discussion - Noor Naffakh, PharmD and Hamsa Sahib, MD


02:45 PM – 03:15 PM  Break & Exhibits


03:15 PM – 04:15 PM  Session 6 - GI Oncology 

Moderator: Prasad Poola, MBBS, FACS, FASCRS

03:15 PM – 03:30 PM  Keynote Lecture: Precision Guided Management of GI Cancers - David Zhen, MD

03:30 PM – 04:15 PM  Case-Based Discussion - Shikha Jain, MD, FACP and Vijay Damarla, MD


04:15 PM – 04:20 PM  Adjourn

Peoria Marriott Pere Marquette
501 Main St
Peoria, IL 61602
United States

A limited number of rooms have been booked at Peoria Marriott Pere Marquette at a discounted nightly rate of $139 per room for this conference's attendees and sponsors. Please book your room at the link here  by March 5, 2024 to receive the discounted group rate.

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

Course Director(s)

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.
Conference Chair(s)

Krishna Rao, MD, PhD

has no relevant financial relationships to disclose at this time.
Session Chair(s)
Speaker/Topic Presenter(s)

Nusayba Bagegni, MD

has a financial relationship (Professional Services) with OncLive/MJH Life Sciences;.

Noah Birch, MD

has no relevant financial relationships to disclose at this time.

Pradeep Chauhan, PhD

has no relevant financial relationships to disclose at this time.

Oana Danciu, MD

has a financial relationship (Other) with Novartis;.
has a financial relationship (Other) with Seagen;.
has a financial relationship (Other) with Novartis;.
has a financial relationship (Other) with Sanofi;.
has a financial relationship (Other) with Pfizer;.

Siddhartha Devarakonda, MBBS, MD

has a financial relationship (Other) with Merus;.
has a financial relationship (Other) with Genetech;.
has a financial relationship (Other) with AZ;.
has a financial relationship (Other) with Jazz;.

Natalie Reizine, MD

has a financial relationship (Financial Support) with Tempus;.
has a financial relationship (Financial Support) with Janssen;.
has a financial relationship (Financial Support) with AstraZeneca;.
has a financial relationship (Financial Support) with Exelexis;.
has a financial relationship (Financial Support) with Merck;.
has a financial relationship (Financial Support) with EMD Serono;.
has a financial relationship (Financial Support) with Sanofi;.

Matias Sanchez, MD

has no relevant financial relationships to disclose at this time.

Parameswaran Venugopal, MD

has a financial relationship (Professional Services) with BeiGene;.

Frank Weinberg, MD, PhD

has a financial relationship (Other) with Jazz Pharmaceuticals;.
has a financial relationship (Other) with TEMPUS Labs;.
has a financial relationship (Other) with Regeneron;.
has a financial relationship (Other) with Amgen;.

David Zhen, MD

has a financial relationship (Grant Or Contract) with Roche/Genentech;.
has a financial relationship (Grant Or Contract) with Seagen;.
has a financial relationship (Grant Or Contract) with Bristol Meyers Squibb;.
has a financial relationship (Grant Or Contract) with Merck;.
has a financial relationship (Grant Or Contract) with Bayer;.
has a financial relationship (Grant Or Contract) with Ipsen;.
has a financial relationship (Independent contractor) with Jazz Pharmaceuticals/Zymeworks, Inc;.
has a financial relationship (Grant Or Contract) with Astra Zeneca;.
has a financial relationship (Grant Or Contract) with Eli Lilly;.
has a financial relationship (Grant Or Contract) with Legend Biotech;.
has a financial relationship (Grant Or Contract) with Daiichi-Sankyo;.
has a financial relationship (Grant Or Contract) with Cornerstone Pharmaceuticals;.
Case Presenter(s)

Waqas Azhar, MD

has a financial relationship (Stock) with Pfizer;.
has a financial relationship (Stock) with Edwards Lifesciences;.
has a financial relationship (Stock) with Bristol-Myers Squibb;.
has a financial relationship (Stock) with Bayer;.

Vijay Damarla

has no relevant financial relationships to disclose at this time.

Shikha Jain, MD

has a financial relationship (Independent contractor) with Seagen;.
has a financial relationship (Independent contractor) with Seagen;.
has a financial relationship (Independent contractor) with Novartis;.
has a financial relationship (Stock) with Doximity;.

Kimberly Ku, MD

has a financial relationship (Grant Or Contract) with PRECEDE (Pancreatic Cancer Early Detection) Consortium ;.

Hamsa Sahib, MD

has no relevant financial relationships to disclose at this time.

Karen Sweiss

has a financial relationship (Professional Services) with Sanofi;.
has a financial relationship (Professional Services) with Pfizer;.
has a financial relationship (Professional Services) with Sanofi;.

Karine Tawagi, MD

has no relevant financial relationships to disclose at this time.
Moderator(s)

Melanie Barnard

has no relevant financial relationships to disclose at this time.

Deepak Kilari

has a financial relationship (Professional Services) with Aveo Oncology ;.
has a financial relationship (Grant Or Contract) with Genentech;.
has a financial relationship (Professional Services) with Jannsen ;.
has a financial relationship (Grant Or Contract) with Exelixis ;.
has a financial relationship (Professional Services) with MJH life science;.
has a financial relationship (Professional Services) with Eisai;.
has a financial relationship (Professional Services) with Astellas ;.

Ryan Nguyen, D.O.

has a financial relationship (Financial Support) with Novartis;.
has a financial relationship (Grant Or Contract) with Exelixis ;.
has a financial relationship (Financial Support) with Merck;.

V. Prasad Poola, MBBS, FACS, FASCRS

has no relevant financial relationships to disclose at this time.
Planning committee(s)

Rakesh Mandal, Staff/Consulting Pathologist, OSF St Francis Medical Center

has no relevant financial relationships to disclose at this time.

Noor Naffakh, PharmD

has no relevant financial relationships to disclose at this time.

Available Credit

  • 6.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

Price

Cost:
$150.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

If your company has purchased an exhibit or sponsorship, please register at the link below to receive the discounted registration fees:

Link to register as an additional rep of a sponsoring company: https://education.binayfoundation.org/industry_registraiton_nocme .

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.